(Q54658293)

2 June 2018

title

Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients. (English)

1 reference

2 June 2018

author

Felix Chun

2

1 reference

2 June 2018

Hartwig Huland

4

Hartwig Huland

1 reference

2 June 2018

Hendrik Isbarn

3

Hendrik Isbarn

1 reference

2 June 2018

Klaus Pantel

5

Klaus Pantel

1 reference

2 June 2018

Heidi Schwarzenbach

1

Heidi Schwarzenbach

1 reference

2 June 2018

publication date

4 August 2010

1 reference

2 June 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

2 June 2018

volume

137

1 reference

2 June 2018

issue

5

1 reference

2 June 2018

page(s)

811-819

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1007/s00432-010-0941-5

exact match

0 references

cites work

PTEN, more than the AKT pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Epigenetic markers for molecular detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Random mutations, selected mutations: A PIN opens the door to new genetic landscapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Intronic deletion affecting a negative regulatory region of TP73 is related to breast and colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0941-5

Genetic pattern of prostate cancer progression

21 January 2018

1 reference

12 December 2020

Multimarker circulating DNA assay for assessing blood of prostate cancer patients

1 reference

12 December 2020

Circulating nucleic acids (CNAs) and cancer--a survey

1 reference

12 December 2020

Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.

1 reference

12 December 2020

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

1 reference

12 December 2020

The origin and mechanism of circulating DNA

1 reference

12 December 2020

Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer

1 reference

12 December 2020

Natural history of prostatic carcinoma: the pathologist's perspective.

1 reference

12 December 2020

10.1007/S00432-010-0941-5

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018